Prochlorperazine Labeling: Indicated for Severe Nausea/Vomiting and Schizophrenia
The FDA approved a new injection to treat severe nausea and schizophrenia when pills cannot be taken
FDA labeling for prochlorperazine lists two approved indications: control of severe nausea and vomiting and treatment of schizophrenia.
A new FDA-approved injection now treats severe nausea and schizophrenia when patients cannot take pills by mouth.
Meta-analysis of 12 studies reports chemotherapy-induced nausea and vomiting prevalence and risk factors in breast cancer patients
Nearly Half of Breast Cancer Patients Face This Rough Side Effect
This meta-analysis pooled data from 12 studies involving breast cancer patients undergoing chemotherapy to assess the prevalence of chemothe…
Knowing who is most likely to get sick from chemo allows doctors to step in before nausea takes over a patient's life.
Oliceridine PCA non-inferior to sufentanil for knee arthroplasty pain, with lower nausea and vomiting
Oliceridine shows similar pain relief to sufentanil after knee surgery with fewer side effects
A randomized controlled trial in 138 elderly patients undergoing knee arthroplasty found Oliceridine patient-controlled analgesia was non-in…
Oliceridine works as well as sufentanil for knee surgery pain but causes less nausea and vomiting in elderly patients.